{"id":"https://openalex.org/W7164992136","doi":"https://doi.org/10.1158/1535-7163.32714575","title":"Supplementary Table S1 from Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune Activation","display_name":"Supplementary Table S1 from Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune Activation","publication_year":2026,"publication_date":"2026-06-17","ids":{"openalex":"https://openalex.org/W7164992136","doi":"https://doi.org/10.1158/1535-7163.32714575"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.32714575","doi":"https://doi.org/10.1158/1535-7163.32714575","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.32714575","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1535-7163.32714575","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056447095","display_name":"Lily L. Nguyen","orcid":"https://orcid.org/0000-0003-4425-2536","observed_orcids":["https://orcid.org/0000-0003-4425-2536"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lily L. Nguyen","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4425-2536","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016493998","display_name":"Zachary L. Watson","orcid":"https://orcid.org/0000-0001-9425-1449","observed_orcids":["https://orcid.org/0000-0001-9425-1449"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zachary L. Watson","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-9425-1449","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022444532","display_name":"Raquel Ortega","orcid":"https://orcid.org/0000-0003-1954-0704","observed_orcids":["https://orcid.org/0000-0003-1954-0704"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Raquel Ortega","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-1954-0704","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068886274","display_name":"Elizabeth R. Woodruff","orcid":"https://orcid.org/0000-0003-0237-7453","observed_orcids":["https://orcid.org/0000-0003-0237-7453"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elizabeth R. Woodruff","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0237-7453","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028795439","display_name":"Kimberly Rae Jordan","orcid":"https://orcid.org/0000-0001-8380-7157","observed_orcids":["https://orcid.org/0000-0001-8380-7157","https://orcid.org/0000-0001-5290-1677"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kimberly R. Jordan","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-8380-7157","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056936160","display_name":"Ritsuko Iwanaga","orcid":"https://orcid.org/0009-0008-1142-4753","observed_orcids":["https://orcid.org/0009-0008-1142-4753"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ritsuko Iwanaga","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0008-1142-4753","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005137433","display_name":"Tomomi M. Yamamoto","orcid":"https://orcid.org/0000-0002-6666-5406","observed_orcids":["https://orcid.org/0000-0002-6666-5406"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tomomi M. Yamamoto","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6666-5406","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004284235","display_name":"Courtney A. Bailey","orcid":"https://orcid.org/0000-0003-0176-7601","observed_orcids":["https://orcid.org/0000-0003-0176-7601"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Courtney A. Bailey","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-0176-7601","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013570540","display_name":"Francis To","orcid":"https://orcid.org/0009-0008-5399-018X","observed_orcids":["https://orcid.org/0009-0008-5399-018X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francis To","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0008-5399-018X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039414993","display_name":"Abigail D. Jeong","orcid":"https://orcid.org/0009-0000-1240-5898","observed_orcids":["https://orcid.org/0009-0000-1240-5898"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Abigail D. Jeong","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0000-1240-5898","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054482532","display_name":"Saketh R. Guntupalli","orcid":"https://orcid.org/0000-0003-2570-6635","observed_orcids":["https://orcid.org/0000-0003-2570-6635"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Saketh R. Guntupalli","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2570-6635","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050160573","display_name":"Kian Behbakht","orcid":"https://orcid.org/0000-0003-4793-9958","observed_orcids":["https://orcid.org/0000-0003-4793-9958"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kian Behbakht","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4793-9958","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084417568","display_name":"Veronica Gibaja","orcid":"https://orcid.org/0009-0008-7785-9362","observed_orcids":["https://orcid.org/0009-0008-7785-9362"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Veronica Gibaja","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0009-0008-7785-9362","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003681202","display_name":"Nausica Arnoult","orcid":"https://orcid.org/0000-0003-2633-0270","observed_orcids":["https://orcid.org/0000-0003-2633-0270"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nausica Arnoult","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-2633-0270","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058456108","display_name":"Alexis\u00a0I. Cocozaki","orcid":"https://orcid.org/0000-0002-3547-552X","observed_orcids":["https://orcid.org/0000-0002-3547-552X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexis Cocozaki","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3547-552X","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039549432","display_name":"Edward B. Chuong","orcid":"https://orcid.org/0000-0002-5392-937X","observed_orcids":["https://orcid.org/0000-0002-5392-937X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Edward B. Chuong","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5392-937X","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5009792132","display_name":"Benjamin Guy Bitler","orcid":"https://orcid.org/0000-0002-5809-5271","observed_orcids":["https://orcid.org/0000-0002-5809-5271"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Benjamin G. Bitler","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5809-5271","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/parp-inhibition","display_name":"PARP inhibition","score":0.972000002861023},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.9319999814033508},{"id":"https://openalex.org/keywords/treatment-resistance","display_name":"treatment resistance","score":0.8690000176429749},{"id":"https://openalex.org/keywords/tumor-growth","display_name":"tumor growth","score":0.7770000100135803},{"id":"https://openalex.org/keywords/immune-activation","display_name":"immune activation","score":0.8550000190734863},{"id":"https://openalex.org/keywords/patient-information","display_name":"patient information","score":0.800000011920929}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6032999753952026},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.5871999859809875},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5738000273704529},{"id":"https://openalex.org/C45235069","wikidata":"https://www.wikidata.org/wiki/Q278425","display_name":"Table (database)","level":2,"score":0.5479000210762024},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5188999772071838},{"id":"https://openalex.org/C26291073","wikidata":"https://www.wikidata.org/wiki/Q310484","display_name":"Ex vivo","level":3,"score":0.48969998955726624},{"id":"https://openalex.org/C2780084626","wikidata":"https://www.wikidata.org/wiki/Q11793790","display_name":"Ovarian tumor","level":4,"score":0.4050999879837036},{"id":"https://openalex.org/C182979987","wikidata":"https://www.wikidata.org/wiki/Q3907241","display_name":"Poly ADP ribose polymerase","level":4,"score":0.3937000036239624},{"id":"https://openalex.org/C3020616263","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Tumor cells","level":2,"score":0.3785000145435333},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3587000072002411},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3472999930381775},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.3375999927520752},{"id":"https://openalex.org/C2993640289","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Solid tumor","level":3,"score":0.3278000056743622},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.2989000082015991},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.29809999465942383},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2971000075340271},{"id":"https://openalex.org/C2780283643","wikidata":"https://www.wikidata.org/wiki/Q2110267","display_name":"Primary tumor","level":4,"score":0.28859999775886536},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.27410000562667847}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1535-7163.32714575","doi":"https://doi.org/10.1158/1535-7163.32714575","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.32714575","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/32714575","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Table_S1_from_Combining_EHMT_and_PARP_Inhibition_A_Strategy_to_Diminish_Therapy-Resistant_Ovarian_Cancer_Tumor_Growth_while_Stimulating_Immune_Activation/32714575","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.32714575","doi":"https://doi.org/10.1158/1535-7163.32714575","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.32714575","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4402222058","https://openalex.org/W4396743411","https://openalex.org/W4404975714","https://openalex.org/W4401542526","https://openalex.org/W4321788879","https://openalex.org/W4392369079","https://openalex.org/W4361932959","https://openalex.org/W3115602503","https://openalex.org/W4394303361"],"abstract_inverted_index":{"Supplementary":[0],"Table":[1],"S1":[2],"shows":[3],"the":[4,8],"patient":[5],"information":[6],"from":[7],"ex":[9],"vivo":[10],"primary":[11],"tumors.":[12]},"counts_by_year":[],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2026-06-18T00:00:00"}